CUTERA INC (CUTR) Fundamental Analysis & Valuation

NASDAQ:CUTR • US2321091082

0.0969 USD
-0.01 (-10.19%)
At close: Mar 12, 2025
0.0381 USD
-0.06 (-60.68%)
After Hours: 3/12/2025, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CUTR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CUTR. CUTR was compared to 184 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of CUTR have multiple concerns. CUTR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. CUTR Profitability Analysis

1.1 Basic Checks

  • CUTR had negative earnings in the past year.
  • In the past year CUTR has reported a negative cash flow from operations.
  • In the past 5 years CUTR reported 4 times negative net income.
  • In the past 5 years CUTR reported 4 times negative operating cash flow.
CUTR Yearly Net Income VS EBIT VS OCF VS FCFCUTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -50M -100M -150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -61.31%, CUTR is doing worse than 73.02% of the companies in the same industry.
Industry RankSector Rank
ROA -61.31%
ROE N/A
ROIC N/A
ROA(3y)-20.69%
ROA(5y)-18.18%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CUTR Yearly ROA, ROE, ROICCUTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400

1.3 Margins

  • CUTR has a worse Gross Margin (5.93%) than 82.01% of its industry peers.
  • CUTR's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CUTR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.52%
GM growth 5Y-16.94%
CUTR Yearly Profit, Operating, Gross MarginsCUTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CUTR Health Analysis

2.1 Basic Checks

  • CUTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CUTR has been increased compared to 1 year ago.
  • The debt/assets ratio for CUTR is higher compared to a year ago.
CUTR Yearly Shares OutstandingCUTR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
CUTR Yearly Total Debt VS Total AssetsCUTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of -3.16, we must say that CUTR is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -3.16, CUTR is doing worse than 64.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.16
ROIC/WACCN/A
WACC2.27%
CUTR Yearly LT Debt VS Equity VS FCFCUTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • CUTR has a Current Ratio of 2.88. This indicates that CUTR is financially healthy and has no problem in meeting its short term obligations.
  • CUTR's Current ratio of 2.88 is in line compared to the rest of the industry. CUTR outperforms 52.91% of its industry peers.
  • CUTR has a Quick Ratio of 1.86. This is a normal value and indicates that CUTR is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.86, CUTR is in line with its industry, outperforming 47.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.88
Quick Ratio 1.86
CUTR Yearly Current Assets VS Current LiabilitesCUTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. CUTR Growth Analysis

3.1 Past

  • The earnings per share for CUTR have decreased strongly by -53.75% in the last year.
  • Looking at the last year, CUTR shows a very negative growth in Revenue. The Revenue has decreased by -32.53% in the last year.
  • CUTR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.47% yearly.
EPS 1Y (TTM)-53.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.73%
Revenue 1Y (TTM)-32.53%
Revenue growth 3Y12.87%
Revenue growth 5Y5.47%
Sales Q2Q%-30.07%

3.2 Future

  • Based on estimates for the next years, CUTR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.52% on average per year.
  • The Revenue is expected to grow by 4.29% on average over the next years.
EPS Next Y-15.64%
EPS Next 2Y12.13%
EPS Next 3Y12.16%
EPS Next 5Y10.52%
Revenue Next Year-32.88%
Revenue Next 2Y-16.2%
Revenue Next 3Y-7.65%
Revenue Next 5Y4.29%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CUTR Yearly Revenue VS EstimatesCUTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
CUTR Yearly EPS VS EstimatesCUTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

0

4. CUTR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CUTR. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CUTR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CUTR Price Earnings VS Forward Price EarningsCUTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CUTR Per share dataCUTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CUTR's earnings are expected to grow with 12.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.13%
EPS Next 3Y12.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CUTR Dividend Analysis

5.1 Amount

  • No dividends for CUTR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CUTR Fundamentals: All Metrics, Ratios and Statistics

CUTERA INC

NASDAQ:CUTR (3/12/2025, 8:00:00 PM)

After market: 0.0381 -0.06 (-60.68%)

0.0969

-0.01 (-10.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-19
Earnings (Next)05-07
Inst Owners33.67%
Inst Owner Change0%
Ins Owners0.61%
Ins Owner Change0%
Market Cap1.96M
Revenue(TTM)155.21M
Net Income(TTM)-143.71M
Analysts80
Price Target2.04 (2005.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-46.13%
Min EPS beat(2)-70.55%
Max EPS beat(2)-21.7%
EPS beat(4)1
Avg EPS beat(4)-25.35%
Min EPS beat(4)-70.55%
Max EPS beat(4)31.14%
EPS beat(8)2
Avg EPS beat(8)-27.63%
EPS beat(12)3
Avg EPS beat(12)-73.2%
EPS beat(16)7
Avg EPS beat(16)33.41%
Revenue beat(2)0
Avg Revenue beat(2)-6.8%
Min Revenue beat(2)-12.9%
Max Revenue beat(2)-0.69%
Revenue beat(4)2
Avg Revenue beat(4)-2.36%
Min Revenue beat(4)-12.9%
Max Revenue beat(4)2.25%
Revenue beat(8)2
Avg Revenue beat(8)-4.68%
Revenue beat(12)3
Avg Revenue beat(12)-2.87%
Revenue beat(16)7
Avg Revenue beat(16)1.32%
PT rev (1m)0%
PT rev (3m)33.33%
EPS NQ rev (1m)9.18%
EPS NQ rev (3m)9.18%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.92
EYN/A
EPS(NY)-3.3
Fwd EYN/A
FCF(TTM)-5.96
FCFYN/A
OCF(TTM)-5.78
OCFYN/A
SpS7.69
BVpS-12.52
TBVpS-12.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -61.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.93%
FCFM N/A
ROA(3y)-20.69%
ROA(5y)-18.18%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.52%
GM growth 5Y-16.94%
F-Score2
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 42.64%
Cap/Sales 2.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.88
Quick Ratio 1.86
Altman-Z -3.16
F-Score2
WACC2.27%
ROIC/WACCN/A
Cap/Depr(3y)442.5%
Cap/Depr(5y)296.69%
Cap/Sales(3y)8.33%
Cap/Sales(5y)5.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.73%
EPS Next Y-15.64%
EPS Next 2Y12.13%
EPS Next 3Y12.16%
EPS Next 5Y10.52%
Revenue 1Y (TTM)-32.53%
Revenue growth 3Y12.87%
Revenue growth 5Y5.47%
Sales Q2Q%-30.07%
Revenue Next Year-32.88%
Revenue Next 2Y-16.2%
Revenue Next 3Y-7.65%
Revenue Next 5Y4.29%
EBIT growth 1Y-45.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-14.52%
EBIT Next 3Y16.97%
EBIT Next 5Y15.93%
FCF growth 1Y-94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-146.55%
OCF growth 3YN/A
OCF growth 5YN/A

CUTERA INC / CUTR FAQ

Can you provide the ChartMill fundamental rating for CUTERA INC?

ChartMill assigns a fundamental rating of 1 / 10 to CUTR.


Can you provide the valuation status for CUTERA INC?

ChartMill assigns a valuation rating of 0 / 10 to CUTERA INC (CUTR). This can be considered as Overvalued.


Can you provide the profitability details for CUTERA INC?

CUTERA INC (CUTR) has a profitability rating of 0 / 10.


Can you provide the financial health for CUTR stock?

The financial health rating of CUTERA INC (CUTR) is 2 / 10.


What is the expected EPS growth for CUTERA INC (CUTR) stock?

The Earnings per Share (EPS) of CUTERA INC (CUTR) is expected to decline by -15.64% in the next year.